"People with heart disease or high heart disease risk are more likely to remain alive, keep their kidney function, and stay off dialysis if they are treated with semaglutide." So, how does a drug developed to help people with type 2 diabetes and popularised as a weight-loss therapy help slow the progression of kidney disease
data in the original s.c./i.v
Semaglutide, a novel GLP-1 analogue, were proved to be effective in treating 2DM and decreasing bodyweight [44, 45], owing to its marked anorexigenic effect [46]
It digests easily and rarely triggers the nausea or bloating that fattier proteins can cause
Although tretinoin is not considered a spot treatment, applying tretinoin to a pimple can indeed contribute to its reduction in size due to its anti-inflammatory properties and its ability to accelerate cell turnover
Based on Obesity Canada guidelines and clinical trials (typically over ~1 year): Saxenda: ~58% total body weight loss Wegovy: ~1015% total body weight loss Tirzepatide: ~1520% (or more) total body weight loss weight loss is gradual and occurs over several months, with the most significant changes seen after reaching the full therapeutic dose results vary depending on adherence, lifestyle factors, and individual response 7